Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;13(6):e12266.
doi: 10.1002/clt2.12266.

The Allergen Immunotherapy Adverse Events Registry: Setup & methodology of a European Academy of Allergy and Clinical Immunology taskforce project

Collaborators, Affiliations

The Allergen Immunotherapy Adverse Events Registry: Setup & methodology of a European Academy of Allergy and Clinical Immunology taskforce project

Julijana Asllani et al. Clin Transl Allergy. 2023 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Julijana Asllani, Alfred Priftanji, Mehmet Hoxha, Gerta Sinani, George Christoff, Dimitrov Zlatko, Michael Makris, Xenofon Aggelidis, Asja Stipic, Diana Deleanu, Vesna Tomic‐Spiric, Aleksandra Plavsic, Dilsad Mungan, Mitja Kosnik have no conflicts of interest to declare. Nikolaos G. Papadopoulos has received grants from Capricare, Nestle, Numil, Vianex and/or fees for consultancy from Abbott, Abbvie, Astra Zeneca, GSK, HAL, Medscape, Menarini/Faes Farma, Mylan, Novartis, Nutricia, OM Pharma, Regeneron/Sanofi in the last 3 years. Dimitrios Mitsias is or recently was a speaker for AstraZeneca, Gerolymatos International, Novartis, Sanofi, in the last 3 years. George Konstantinou is or recently was a speaker and/or advisor for and/or has received research funding from AstraZeneca, Chiesi, GSK, Menarini, Novartis, Pfizer, Sanofi, and Vianex in the last 3 years. All other authors do not declare any conflicts of interest.

European Academy of Allergy and Clinical Immunology; Stallergenes

References

    1. Dhami S, Nurmatov U, Arasi S, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta‐analysis. Allergy. 2017;72(11):1597‐1631. 10.1111/all.13201 - DOI - PubMed
    1. Valovirta E, Petersen TH, Piotrowska T, et al. Results from the 5‐year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy. J Allergy Clin Immunol. 2018;141(2):529‐538. 10.1016/j.jaci.2017.06.014 - DOI - PubMed
    1. Roche N, Anzueto A, Bosnic Anticevich S, et al. The importance of real‐life research in respiratory medicine: manifesto of the Respiratory Effectiveness Group. Eur Respir J. 2019;54(3):1901511. 10.1183/13993003.01511-2019 - DOI - PubMed
    1. Calderon MA, Vidal C, Rodríguez del Río P, et al. European survey on adverse systemic reactions in allergen immunotherapy (EASSI): a real‐life clinical assessment. Allergy. 2017;72(3):462‐472. 10.1111/all.13066 - DOI - PubMed
    1. Tophof MA, Hermanns A, Adelt T, et al. Side effects during subcutaneous immunotherapy in children with allergic diseases. Pediatr Allergy Immunol. 2018;29(3):267‐274. Epub 2018 Jan 17. PMID: 29247543. 10.1111/pai.12847 - DOI - PubMed